Back to products
Next product
Tazverik (tazemetostat)
CHF27,178.54
Enhertu (fam-trastuzumab deruxtecan-nxki)
CHF3,965.00
Enhertu (fam-trastuzumab deruxtecan-nxki) is a medication used for the treatment of adult patients with advanced HER+ breast cancer or with advanced HER2+ stomach (gastric) or gastroesophageal junction (GEJ) cancer.
Reviews
There are no reviews yet.